Stage models for major depression: Cognitive behavior therapy, mechanistic treatment targets, and the prevention of stage transition
- PMID: 35688097
- PMCID: PMC9257701
- DOI: 10.1016/j.cpr.2022.102172
Stage models for major depression: Cognitive behavior therapy, mechanistic treatment targets, and the prevention of stage transition
Abstract
Stage models encourage a longitudinal perspective on the care of those with major depression: supporting vigilance to the risk for stage progression and the selection of interventions to address that risk. A central goal for this article is to evaluate the role of cognitive-behavior therapy (CBT) in addressing stage progression in the treatment of major depression. We summarize the evidence supporting depression-focused CBT for: (1) preventing depression onset, (2) treating syndromal depression, (3) treating residual symptoms, (4) preventing relapse, and (5) addressing pharmacologic treatment resistance. In addition, consistent with the goal of aiding prevention and intervention development by refining mechanistic treatment targets, we evaluate the role of two specific risk-factors for stage progression: insomnia and rumination. These risk factors have a feed-forward relationship with stress, both being amplified by stress and amplifying the negative consequences of stress. Moreover, each of these risk factors predict depression stage transmissions across multiple stages, and both are modifiable with treatment. Accordingly, insomnia and rumination appear to serve as excellent mechanistic targets for the prevention of depression stage progression. These findings are discussed in relation to current limitations and future research directions for targeting these risk factors and furthering the effective treatment of depression.
Keywords: Depression; Insomnia; Mechanistic target; Relapse; Rumination; Sleep; Stage model.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy for insomnia versus sleep education control to prevent major depression.Trials. 2022 Dec 1;23(1):967. doi: 10.1186/s13063-022-06850-4. Trials. 2022. PMID: 36457045 Free PMC article.
-
Treating Insomnia with High Risk of Depression Using Therapist-Guided Digital Cognitive, Behavioral, and Circadian Rhythm Support Interventions to Prevent Worsening of Depressive Symptoms: A Randomized Controlled Trial.Psychother Psychosom. 2022;91(3):168-179. doi: 10.1159/000520282. Epub 2021 Dec 6. Psychother Psychosom. 2022. PMID: 34872087 Clinical Trial.
-
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial.JAMA Psychiatry. 2022 Jan 1;79(1):33-41. doi: 10.1001/jamapsychiatry.2021.3422. JAMA Psychiatry. 2022. PMID: 34817561 Free PMC article. Clinical Trial.
-
Cognitive Behavioural Therapy for Insomnia (CBT-I) to treat depression: A systematic review.J Psychosom Res. 2018 Mar;106:1-12. doi: 10.1016/j.jpsychores.2017.12.012. Epub 2017 Dec 24. J Psychosom Res. 2018. PMID: 29455893
-
The Impact of Cognitive-Behavioral Interventions on Sleep Disturbance in Depressed and Anxious Community-dwelling Older Adults: A Systematic Review.Behav Sleep Med. 2022 Jul-Aug;20(4):477-499. doi: 10.1080/15402002.2021.1933488. Epub 2021 Jun 14. Behav Sleep Med. 2022. PMID: 34120539
Cited by
-
Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.Psychedelic Med (New Rochelle). 2023 Dec 13;1(4):230-240. doi: 10.1089/psymed.2023.0018. eCollection 2023 Dec. Psychedelic Med (New Rochelle). 2023. PMID: 40046861 Free PMC article.
-
A systematic review of the effects of rumination-focused cognitive behavioral therapy in reducing depressive symptoms.Front Psychol. 2024 Dec 3;15:1447207. doi: 10.3389/fpsyg.2024.1447207. eCollection 2024. Front Psychol. 2024. PMID: 39691663 Free PMC article. Review.
-
Rumination-Focused Cognitive Behavioral Therapy Reduces Rumination and Targeted Cross-network Connectivity in Youth With a History of Depression: Replication in a Preregistered Randomized Clinical Trial.Biol Psychiatry Glob Open Sci. 2023 Nov 3;4(1):1-10. doi: 10.1016/j.bpsgos.2023.08.012. eCollection 2024 Jan. Biol Psychiatry Glob Open Sci. 2023. PMID: 38021251 Free PMC article.
-
An Experimental Therapeutics Focus on Novel Mechanistic Targets in Cognitive Behavioral Treatments: Introduction to the Special Section.Behav Ther. 2023 Jul;54(4):605-609. doi: 10.1016/j.beth.2023.02.002. Epub 2023 Feb 16. Behav Ther. 2023. PMID: 37330251 Free PMC article.
-
Next-Generation Cognitive-Behavioral Therapy for Depression: Integrating Digital Tools, Teletherapy, and Personalization for Enhanced Mental Health Outcomes.Medicina (Kaunas). 2025 Feb 28;61(3):431. doi: 10.3390/medicina61030431. Medicina (Kaunas). 2025. PMID: 40142242 Free PMC article.
References
-
- Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, & Riemann D (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135, 10–19. 10.1016/j.jad.2011.01.011 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical